{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:45:42Z","timestamp":1788630342347,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foshan Municipal Science and Technology Innovation Project","award":["2520001002968"],"award-info":[{"award-number":["2520001002968"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200519"],"award-info":[{"award-number":["82200519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-026-07896-1","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:13:46Z","timestamp":1783404826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complement Component C4B Prioritization Through Drug\u2012Target Mendelian Randomization and Proteomic Analysis Reveals a Novel Therapeutic Target for Calcific Aortic Valve Stenosis"],"prefix":"10.1007","author":[{"given":"Weijie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"47","key":"7896_CR1","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/eurheartj\/ehw229","volume":"37","author":"JL d\u2019 Arcy","year":"2016","unstructured":"d\u2019Arcy JL, Coffey S, Loudon MA, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37(47):3515\u201322. https:\/\/doi.org\/10.1093\/eurheartj\/ehw229.","journal-title":"Eur Heart J"},{"issue":"8","key":"7896_CR2","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1056\/NEJMra1313875","volume":"371","author":"CM Otto","year":"2014","unstructured":"Otto CM, Prendergast B. Aortic-valve stenosis\u2013from patients at risk to severe valve obstruction. N Engl J Med. 2014;371(8):744\u201356. https:\/\/doi.org\/10.1056\/NEJMra1313875.","journal-title":"N Engl J Med"},{"issue":"9","key":"7896_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/biom9090472","volume":"9","author":"S Singh","year":"2019","unstructured":"Singh S, Torzewski M. Fibroblasts and their pathological functions in the fibrosis of aortic valve sclerosis and atherosclerosis. Biomolecules. 2019;9(9):472. https:\/\/doi.org\/10.3390\/biom9090472.","journal-title":"Biomolecules"},{"issue":"6","key":"7896_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2022.05.006","volume":"75","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition). 2022;75(6):524. https:\/\/doi.org\/10.1016\/j.rec.2022.05.006.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"13","key":"7896_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","volume":"359","author":"AB Rosseb\u00f8","year":"2008","unstructured":"Rosseb\u00f8 AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343\u201356. https:\/\/doi.org\/10.1056\/NEJMoa0804602.","journal-title":"N Engl J Med"},{"issue":"2","key":"7896_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","volume":"121","author":"KL Chan","year":"2010","unstructured":"Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation. 2010;121(2):306\u201314. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.900027.","journal-title":"Circulation"},{"issue":"7","key":"7896_CR7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/CIRCULATIONAHA.118.035236","volume":"139","author":"SJ Baron","year":"2019","unstructured":"Baron SJ, Wang K, House JA, et al. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk. Circulation. 2019;139(7):877\u201388. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035236.","journal-title":"Circulation"},{"issue":"12","key":"7896_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","volume":"354","author":"JC Cohen","year":"2006","unstructured":"Cohen JC, Boerwinkle E, Mosley TH Jr., Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354(12):1264\u201372. https:\/\/doi.org\/10.1056\/NEJMoa054013.","journal-title":"N Engl J Med"},{"issue":"1","key":"7896_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54849-w","volume":"9","author":"AD Hingorani","year":"2019","unstructured":"Hingorani AD, Kuan V, Finan C, et al. Improving the odds of drug development success through human genomics: modelling study. Sci Rep. 2019;9(1):18911. https:\/\/doi.org\/10.1038\/s41598-019-54849-w.","journal-title":"Sci Rep"},{"issue":"9","key":"7896_CR10","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd892","volume":"1","author":"AL Hopkins","year":"2002","unstructured":"Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1(9):727\u201330. https:\/\/doi.org\/10.1038\/nrd892.","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"7896_CR11","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/eurheartj\/ehad142","volume":"44","author":"H Yu Chen","year":"2023","unstructured":"Yu Chen H, Dina C, Small AM, et al. Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study. Eur Heart J. 2023;44(21):1927\u201339. https:\/\/doi.org\/10.1093\/eurheartj\/ehad142.","journal-title":"Eur Heart J"},{"issue":"9501","key":"7896_CR12","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(05)67767-7","volume":"366","author":"A Hingorani","year":"2005","unstructured":"Hingorani A, Humphries S. Nature\u2019s randomised trials. Lancet. 2005;366(9501):1906\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(05)67767-7.","journal-title":"Lancet"},{"issue":"19","key":"7896_CR13","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925\u20136. https:\/\/doi.org\/10.1001\/jama.2017.17219.","journal-title":"JAMA"},{"issue":"1","key":"7896_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Mara\u00f1\u00f3n M, et al. Genetic drug target validation using Mendelian randomisation. Nat Commun. 2020;11(1):3255. https:\/\/doi.org\/10.1038\/s41467-020-16969-0.","journal-title":"Nat Commun"},{"issue":"383","key":"7896_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9(383):aag1166. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166.","journal-title":"Sci Transl Med"},{"issue":"9","key":"7896_CR16","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z.","journal-title":"Nat Genet"},{"issue":"1620","key":"7896_CR17","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2012.0362","volume":"368","author":"AC Nica","year":"2013","unstructured":"Nica AC, Dermitzakis ET. Expression quantitative trait loci: present and future. Philos Trans R Soc Lond B Biol Sci. 2013;368(1620):20120362. https:\/\/doi.org\/10.1098\/rstb.2012.0362.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"7896_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740\u201352. https:\/\/doi.org\/10.1093\/ije\/dyq151.","journal-title":"Int J Epidemiol"},{"issue":"7422","key":"7896_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"Abecasis GR, Auton A, Brooks LD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56\u201365. https:\/\/doi.org\/10.1038\/nature11632.","journal-title":"Nature"},{"key":"7896_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3.","journal-title":"Wellcome Open Res"},{"issue":"5","key":"7896_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x.","journal-title":"Eur J Epidemiol"},{"key":"7896_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.artmed.2017.02.001","volume":"76","author":"L Chen","year":"2017","unstructured":"Chen L, Zhang YH, Lu G, Huang T, Cai YD. Analysis of cancer-related lncRNAs using gene ontology and KEGG pathways. Artif Intell Med. 2017;76:27\u201336. https:\/\/doi.org\/10.1016\/j.artmed.2017.02.001.","journal-title":"Artif Intell Med"},{"issue":"5","key":"7896_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"14","key":"7896_CR24","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C. Pathview: an R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830\u20131. https:\/\/doi.org\/10.1093\/bioinformatics\/btt285.","journal-title":"Bioinformatics"},{"issue":"5","key":"7896_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383.","journal-title":"PLoS Genet"},{"issue":"1","key":"7896_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01140-9","volume":"14","author":"C Yang","year":"2022","unstructured":"Yang C, Fagan AM, Perrin RJ, et al. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes. Genome Med. 2022;14(1):140. https:\/\/doi.org\/10.1186\/s13073-022-01140-9.","journal-title":"Genome Med"},{"issue":"5","key":"7896_CR27","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods. 2009;6(5):359\u201362. https:\/\/doi.org\/10.1038\/nmeth.1322.","journal-title":"Nat Methods"},{"issue":"11","key":"7896_CR28","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13(11):e1007081. https:\/\/doi.org\/10.1371\/journal.pgen.1007081.","journal-title":"PLoS Genet"},{"issue":"7877","key":"7896_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang Q, Dhindsa RS, Carss K, et al. Rare variant contribution to human disease in 281,104 UK Biobank exomes. Nature. 2021;597(7877):527\u201332. https:\/\/doi.org\/10.1038\/s41586-021-03855-y.","journal-title":"Nature"},{"issue":"6","key":"7896_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF00396104","volume":"25","author":"CY Yu","year":"1987","unstructured":"Yu CY, Campbell RD. Definitive RFLPs to distinguish between the human complement C4A\/C4B isotypes and the major Rodgers\/Chido determinants: application to the study of C4 null alleles. Immunogenetics. 1987;25(6):383\u201390. https:\/\/doi.org\/10.1007\/BF00396104.","journal-title":"Immunogenetics"},{"key":"7896_CR31","doi-asserted-by":"publisher","first-page":"694928","DOI":"10.3389\/fimmu.2021.694928","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Liu M. Complement C4, Infections, and Autoimmune Diseases. Front Immunol. 2021;12:694928. https:\/\/doi.org\/10.3389\/fimmu.2021.694928.","journal-title":"Front Immunol"},{"issue":"14","key":"7896_CR32","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ, Complement. First of two parts. N Engl J Med. 2001;344(14):1058\u201366. https:\/\/doi.org\/10.1056\/NEJM200104053441406.","journal-title":"N Engl J Med"},{"key":"7896_CR33","doi-asserted-by":"publisher","unstructured":"Nauta AJ, Daha MR, Tijsma O, et al. The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol. 2002;32(3):783\u201392. https:\/\/doi.org\/10.1002\/1521-4141(200203)32:3U+003C783::AID-IMMU783U+003E3.0.CO;2-Q.","DOI":"10.1002\/1521-4141(200203)32:3U+003C783::AID-IMMU783U+003E3.0.CO;2-Q"},{"issue":"5","key":"7896_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10735-020-09905-5","volume":"51","author":"J Lim","year":"2020","unstructured":"Lim J, Aguilan JT, Sellers RS, et al. Lipid mass spectrometry imaging and proteomic analysis of severe aortic stenosis. J Mol Histol. 2020;51(5):559\u201371. https:\/\/doi.org\/10.1007\/s10735-020-09905-5.","journal-title":"J Mol Histol"},{"issue":"1","key":"7896_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2007.03.040","volume":"196","author":"S Helske","year":"2008","unstructured":"Helske S, Oksjoki R, Lindstedt KA, et al. Complement system is activated in stenotic aortic valves. Atherosclerosis. 2008;196(1):190\u2013200. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.03.040.","journal-title":"Atherosclerosis"},{"issue":"12","key":"7896_CR36","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/CIRCRESAHA.110.234237","volume":"108","author":"JH Chen","year":"2011","unstructured":"Chen JH, Simmons CA. Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res. 2011;108(12):1510\u201324. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.234237.","journal-title":"Circ Res"},{"key":"7896_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jss.2022.12.028","volume":"286","author":"XS Deng","year":"2023","unstructured":"Deng XS, Meng X, Fullerton D, et al. Complement cross talks with H-K-ATPase to upregulate Runx2 in human aortic valve interstitial cells. J Surg Res. 2023;286:118\u201326. https:\/\/doi.org\/10.1016\/j.jss.2022.12.028.","journal-title":"J Surg Res"},{"issue":"6","key":"7896_CR38","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/j.athoracsur.2020.12.058","volume":"112","author":"XS Deng","year":"2021","unstructured":"Deng XS, Meng X, Fullerton D, Stone M, Jaggers J. Complement upregulates Runx-2 to induce profibrogenic change in aortic valve interstitial cells. Ann Thorac Surg. 2021;112(6):1962\u201372. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.12.058.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"7896_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G. Overview of complement activation and regulation. Semin Nephrol. 2013;33(6):479\u201392. https:\/\/doi.org\/10.1016\/j.semnephrol.2013.08.001.","journal-title":"Semin Nephrol"},{"issue":"8","key":"7896_CR40","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/cbf.3858","volume":"41","author":"S Li","year":"2023","unstructured":"Li S, Ruan J, Yang Z, Liu L, Jiang T. In silico analysis and verification of critical genes related to vascular calcification in multiple diseases. Cell Biochem Funct. 2023;41(8):1242\u201351. https:\/\/doi.org\/10.1002\/cbf.3858.","journal-title":"Cell Biochem Funct"},{"issue":"16","key":"7896_CR41","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","volume":"124","author":"NM Rajamannan","year":"2011","unstructured":"Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: calcific aortic valve disease-2011 update. Circulation. 2011;124(16):1783\u201391. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.006767.","journal-title":"Circulation"},{"issue":"23","key":"7896_CR42","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1056\/NEJMoa043876","volume":"352","author":"SJ Cowell","year":"2005","unstructured":"Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352(23):2389\u201397. https:\/\/doi.org\/10.1056\/NEJMoa043876.","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"7896_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.0300-9475.2004.01439.x","volume":"60","author":"KT Lappeg\u00e5rd","year":"2004","unstructured":"Lappeg\u00e5rd KT, Hvassing T, Mollnes TE. Statin drugs do not affect serum complement activation in vitro. Scand J Immunol. 2004;60(1\u20132):178\u201383. https:\/\/doi.org\/10.1111\/j.0300-9475.2004.01439.x.","journal-title":"Scand J Immunol"},{"issue":"9","key":"7896_CR44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1634\/theoncologist.2008-0086","volume":"13","author":"A Dmytrijuk","year":"2008","unstructured":"Dmytrijuk A, Robie-Suh K, Cohen MH, et al. FDA report: Eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Oncologist. 2008;13(9):993\u20131000. https:\/\/doi.org\/10.1634\/theoncologist.2008-0086.","journal-title":"Oncologist"},{"key":"7896_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106311","volume":"95","author":"GD Vieira","year":"2025","unstructured":"Vieira GD, Boldrini VO, Mader S, et al. Ravulizumab and other complement inhibitors for the treatment of autoimmune disorders. Mult Scler Relat Disord. 2025;95:106311. https:\/\/doi.org\/10.1016\/j.msard.2025.106311.","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"7896_CR46","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1111\/trf.12501","volume":"54","author":"I Martinez-Saguer","year":"2014","unstructured":"Martinez-Saguer I, Cicardi M, Suffritti C, et al. Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study. Transfusion. 2014;54(6):1552\u201361. https:\/\/doi.org\/10.1111\/trf.12501.","journal-title":"Transfusion"},{"issue":"1","key":"7896_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0008-8749(85)90337-5","volume":"96","author":"JN Goldman","year":"1985","unstructured":"Goldman JN, O\u2019Rourke KS, Goldman MB. Antibody-induced suppression and postsuppression stimulation of complement in vitro. III. Long-term C4 suppression is actively maintained by a soluble suppressor factor (FsC4). Cell Immunol. 1985;96(1):26\u201337. https:\/\/doi.org\/10.1016\/0008-8749(85)90337-5.","journal-title":"Cell Immunol"},{"issue":"12","key":"7896_CR48","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.4049\/jimmunol.1700779","volume":"200","author":"Y Qaddoori","year":"2018","unstructured":"Qaddoori Y, Abrams ST, Mould P, et al. Extracellular histones inhibit complement activation through interacting with complement component 4. J Immunol. 2018;200(12):4125\u201333. https:\/\/doi.org\/10.4049\/jimmunol.1700779.","journal-title":"J Immunol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07896-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:13:48Z","timestamp":1783404828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07896-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":48,"alternative-id":["7896"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07896-1","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data used in the MR analysis have been ethically approved and informed consent has been obtained from all participants in the original research.The human study was approved by the Research Ethics Committee of the First People\u2019s Hospital of Foshan (Foshan, Guangdong, P. R. China) in compliance with the declaration of Helsinki and International Conference on Harmonization guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}